SCM
STLN

Sterling Capital Management’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Sterling Capital Management’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08K Buy
567
+49
+9% +$206 ﹤0.01% 2860
2026
Q1 		$1.59K Buy
518
+128
+33% +$392 ﹤0.01% 3031
2025
Q4 		$1.39K Buy
390
+245
+169% +$909 ﹤0.01% 3110
2025
Q3 		$506 Buy
145
+2
+1% +$7 ﹤0.01% 3158
2025
Q2 		$293 Buy
+143
New +$358 ﹤0.01% 3207

Other funds holding STLN

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
IAAG
Innovative Asset Advisors Group Shelton, Connecticut $229M AUM

Sterling Capital Management's STLN Position: Q2 2026 in Review

Sterling Capital Management increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 9.5% in Q2 2026, buying an estimated $206 and bringing the position to 567 shares worth $3.08K. The position accounts for ﹤0.01% of the portfolio, ranked #2860.

Sterling Capital Management first reported a position in STLN in Q2 2025 and has held it in 5 quarters since. 29 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Sterling Capital Management held 567 shares of Starling Oncology Institute, Inc. Common Stock worth $3.08K as of Q2 2026.
  • Sterling Capital Management bought 49 Starling Oncology Institute, Inc. Common Stock shares in Q2 2026, an estimated $206.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2860 holding.
  • Sterling Capital Management first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2025 and has held it in 5 quarters since.
  • 29 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.